1 Boring Old Man scrutinizes the evidence that Johnson & Johnson hid evidence of Risperdal’s breast-growing properties, among other improper actions, concluding “The story is much bigger than this trial, or for that matter, the sum of their trials. It’s a story about a massive and successful scheme to actually control the practice of psychiatry in the country in order to profit from the sale of Risperdal. The target populations were people with Schizophrenia or others in the States’ public mental health systems, disturbed children many of whom were also under some form of government supervision, and the elderly in nursing care facilities.”
